{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:37:34Z","timestamp":1784543854099,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401745"],"award-info":[{"award-number":["82401745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471271"],"award-info":[{"award-number":["82471271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Parkinson\u2019s Progression Markers Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00415-025-13359-8","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T08:00:10Z","timestamp":1757750410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal decline in striatal DAT binding in LRRK2 Parkinson\u2019s disease: connections with CSF \u03b1-synuclein seeding activity"],"prefix":"10.1007","volume":"272","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8695-2296","authenticated-orcid":false,"given":"Ruihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"13359_CR1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/mds.27431","volume":"33","author":"D Berg","year":"2018","unstructured":"Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schaffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB (2018) Movement disorder society criteria for clinically established early Parkinson\u2019s disease. Mov Disord 33:1643\u20131646","journal-title":"Mov Disord"},{"key":"13359_CR2","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/15548627.2021.1936933","volume":"17","author":"CA Boecker","year":"2021","unstructured":"Boecker CA, Holzbaur ELF (2021) Hyperactive LRRK2 kinase impairs the trafficking of axonal autophagosomes. Autophagy 17:2043\u20132045","journal-title":"Autophagy"},{"key":"13359_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62:133\u2013140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13359_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"13359_CR5","doi-asserted-by":"crossref","first-page":"e1691","DOI":"10.1212\/WNL.0000000000207077","volume":"100","author":"MC Brumm","year":"2023","unstructured":"Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K (2023) Updated percentiles for the University of Pennsylvania smell identification test in adults 50 years of age and older. Neurology 100:e1691\u2013e1701","journal-title":"Neurology"},{"key":"13359_CR6","doi-asserted-by":"crossref","first-page":"fcaf103","DOI":"10.1093\/braincomms\/fcaf103","volume":"7","author":"LM Chahine","year":"2025","unstructured":"Chahine LM, Lafontant DE, Choi SH, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-Latapi P, Avants B, Coffey C, Jennings D, Tolosa E, Siderowf A, Marek K, Simuni T, Parkinson\u2019s Progression Markers I (2025) LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization. Brain Commun 7:fcaf103","journal-title":"Brain Commun"},{"key":"13359_CR7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18:1179\u20131196","journal-title":"Nat Protoc"},{"key":"13359_CR8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejn.14182","volume":"49","author":"N Cresto","year":"2019","unstructured":"Cresto N, Gardier C, Gubinelli F, Gaillard MC, Liot G, West AB, Brouillet E (2019) The unlikely partnership between LRRK2 and alpha-synuclein in Parkinson\u2019s disease. Eur J Neurosci 49:339\u2013363","journal-title":"Eur J Neurosci"},{"key":"13359_CR9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/qjmed\/hcq142","volume":"103","author":"J Deeb","year":"2010","unstructured":"Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH (2010) A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson\u2019s disease. QJM 103:941\u2013952","journal-title":"QJM"},{"key":"13359_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41531-024-00854-4","volume":"11","author":"A Droby","year":"2025","unstructured":"Droby A, Yoffe-Vasiliev A, Atias D, Fraser KB, Mabrouk OS, Omer N, Bar-Shira A, Gana-Weisz M, Goldstein O, Artzi M, Ben Bashat D, Alcalay RN, Orr-Urtreger A, Shirvan JC, Cedarbaum JM, Giladi N, Mirelman A, Thaler A (2025) Radiological markers of CSF alpha-synuclein aggregation in Parkinson\u2019s disease patients. NPJ Parkinsons Dis 11:7","journal-title":"NPJ Parkinsons Dis"},{"key":"13359_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fnins.2020.00719","volume":"14","author":"DJ Dues","year":"2020","unstructured":"Dues DJ, Moore DJ (2020) LRRK2 and protein aggregation in Parkinson\u2019s disease: insights from animal models. Front Neurosci 14:719","journal-title":"Front Neurosci"},{"key":"13359_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27223","author":"V Dzialas","year":"2025","unstructured":"Dzialas V, Bischof GN, Mollenhoff K, Drzezga A, van Eimeren T (2025) Dopamine transporter imaging as objective monitoring biomarker in Parkinson\u2019s disease. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.27223","journal-title":"Ann Neurol"},{"key":"13359_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818","journal-title":"Ann Clin Transl Neurol"},{"key":"13359_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s42003-024-06256-9","volume":"7","author":"P Fang","year":"2024","unstructured":"Fang P, Yu LW, Espey H, Agirman G, Kazmi SA, Li K, Deng Y, Lee J, Hrncir H, Romero-Lopez A, Arnold AP, Hsiao EY (2024) Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson\u2019s disease. Commun Biol 7:570","journal-title":"Commun Biol"},{"key":"13359_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.29284","volume":"38","author":"A Garrido","year":"2023","unstructured":"Garrido A, Fairfoul G, Tolosa E, Marti MJ, Ezquerra M, Green AJE (2023) Brain and cerebrospinal fluid alpha-synuclein real-time quaking-induced conversion identifies Lewy body pathology in LRRK2-PD. Mov Disord 38:333\u2013338","journal-title":"Mov Disord"},{"key":"13359_CR16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/acn3.772","volume":"6","author":"A Garrido","year":"2019","unstructured":"Garrido A, Fairfoul G, Tolosa ES, Marti MJ, Green A, Barcelona LSG (2019) alpha-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson\u2019s disease. Ann Clin Transl Neurol 6:1024\u20131032","journal-title":"Ann Clin Transl Neurol"},{"key":"13359_CR17","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1007\/s12035-015-9209-z","volume":"53","author":"PS Guerreiro","year":"2016","unstructured":"Guerreiro PS, Gerhardt E, Lopes da Fonseca T, Bahr M, Outeiro TF, Eckermann K (2016) LRRK2 promotes Tau accumulation, aggregation and release. Mol Neurobiol 53:3124\u20133135","journal-title":"Mol Neurobiol"},{"key":"13359_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-022-01388-7","volume":"10","author":"S Hall","year":"2022","unstructured":"Hall S, Orru CD, Serrano GE, Galasko D, Hughson AG, Groveman BR, Adler CH, Beach TG, Caughey B, Hansson O (2022) Performance of alphaSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun 10:90","journal-title":"Acta Neuropathol Commun"},{"key":"13359_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/genes12040505","author":"EM Hur","year":"2021","unstructured":"Hur EM, Lee BD (2021) LRRK2 at the crossroad of aging and Parkinson\u2019s disease. Genes. https:\/\/doi.org\/10.3390\/genes12040505","journal-title":"Genes"},{"key":"13359_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5607\/en.2013.22.4.249","volume":"22","author":"CH Hyun","year":"2013","unstructured":"Hyun CH, Yoon CY, Lee HJ, Lee SJ (2013) LRRK2 as a potential genetic modifier of synucleinopathies: interlacing the two major genetic factors of Parkinson\u2019s disease. Exp Neurobiol 22:249\u2013257","journal-title":"Exp Neurobiol"},{"key":"13359_CR21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martinez J, Marti-Masso JF, Ferrer I, Lopez de Munain A, Goldman SM, Schule B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105","journal-title":"JAMA Neurol"},{"key":"13359_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ, Green A, Soto C (2019) Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov Disord 34:536\u2013544","journal-title":"Mov Disord"},{"key":"13359_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2017.05.006","volume":"57","author":"TM Karrer","year":"2017","unstructured":"Karrer TM, Josef AK, Mata R, Morris ED, Samanez-Larkin GR (2017) Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis. Neurobiol Aging 57:36\u201346","journal-title":"Neurobiol Aging"},{"key":"13359_CR24","doi-asserted-by":"crossref","first-page":"e0210248","DOI":"10.1371\/journal.pone.0210248","volume":"14","author":"J Kim","year":"2019","unstructured":"Kim J, Pajarillo E, Rizor A, Son DS, Lee J, Aschner M, Lee E (2019) LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia. PLoS ONE 14:e0210248","journal-title":"PLoS ONE"},{"key":"13359_CR25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318:876\u2013880","journal-title":"N Engl J Med"},{"key":"13359_CR26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma Y, Farris CM, Weber S, Schade S, Nguyen H, Perez-Soriano A, Giraldo DM, Fernandez M, Soto M, Camara A, Painous C, Munoz E, Valldeoriola F, Marti MJ, Clarimon J, Kallunki P, Ma TC, Alcalay RN, Gomes BF, Blennow K, Zetterberg H, Constantinescu J, Mengel D, Kadam V, Parchi P, Brockmann K, Tropea TF, Siderowf A, Synofzik M, Kang UJ, Compta Y, Svenningsson P, Mollenhauer B, Concha-Marambio L (2024) Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol 23:1225\u20131237","journal-title":"Lancet Neurol"},{"key":"13359_CR27","doi-asserted-by":"crossref","first-page":"fcz052","DOI":"10.1093\/braincomms\/fcz052","volume":"2","author":"S MacIsaac","year":"2020","unstructured":"MacIsaac S, Quevedo Melo T, Zhang Y, Volta M, Farrer MJ, Milnerwood AJ (2020) Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-out. Brain Commun 2:fcz052","journal-title":"Brain Commun"},{"key":"13359_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46:329\u2013343","journal-title":"Trends Biochem Sci"},{"key":"13359_CR29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T, Parkinson\u2019s Progression Markers I (2018) The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol 5:1460\u20131477","journal-title":"Ann Clin Transl Neurol"},{"key":"13359_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2018.06.022","volume":"56","author":"YS Oh","year":"2018","unstructured":"Oh YS, Kim JS, Hwang EJ, Lyoo CH (2018) Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson\u2019s disease. Parkinsonism Relat Disord 56:47\u201351","journal-title":"Parkinsonism Relat Disord"},{"key":"13359_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-022-00281-6","volume":"11","author":"SY Pang","year":"2022","unstructured":"Pang SY, Lo RCN, Ho PW, Liu HF, Chang EES, Leung CT, Malki Y, Choi ZY, Wong WY, Kung MH, Ramsden DB, Ho SL (2022) LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson\u2019s disease. Transl Neurodegener 11:5","journal-title":"Transl Neurodegener"},{"key":"13359_CR32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"The Parkinson Progression Marker Initiative (PPMI)","year":"2011","unstructured":"The Parkinson Progression Marker Initiative (PPMI) (2011) Parkinson progression marker I. Prog Neurobiol 95:629\u2013635","journal-title":"Prog Neurobiol"},{"key":"13359_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orru CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G, Ladogana A, Plazzi G, Cortelli P, Caughey B, Parchi P (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362","journal-title":"Acta Neuropathol"},{"key":"13359_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-11-52","volume":"11","author":"I Russo","year":"2014","unstructured":"Russo I, Bubacco L, Greggio E (2014) LRRK2 and neuroinflammation: partners in crime in Parkinson\u2019s disease? J Neuroinflammation 11:52","journal-title":"J Neuroinflammation"},{"key":"13359_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo MJ, Orru CD, Concha-Marambio L, Giaisi S, Groveman BR, Farris CM, Holguin B, Hughson AG, LaFontant DE, Caspell-Garcia C, Coffey CS, Mollon J, Hutten SJ, Merchant K, Heym RG, Soto C, Caughey B, Kang UJ (2021) High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol Commun 9:179","journal-title":"Acta Neuropathol Commun"},{"key":"13359_CR36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523","journal-title":"Mov Disord"},{"key":"13359_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C (2017) Development of a biochemical diagnosis of Parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163\u2013172","journal-title":"JAMA Neurol"},{"key":"13359_CR38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson\u2019s Progression Markers I (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417","journal-title":"Lancet Neurol"},{"key":"13359_CR39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","volume":"19","author":"T Simuni","year":"2020","unstructured":"Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K, Investigators P (2020) Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol 19:71\u201380","journal-title":"Lancet Neurol"},{"key":"13359_CR40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"13359_CR41","doi-asserted-by":"crossref","first-page":"eadl1535","DOI":"10.1126\/scitranslmed.adl1535","volume":"16","author":"RL Wallings","year":"2024","unstructured":"Wallings RL, McFarland K, Staley HA, Neighbarger N, Schaake S, Bruggemann N, Zittel S, Usnich T, Klein C, Sammler EM, Tansey MG (2024) The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in mice. Sci Transl Med 16:eadl1535","journal-title":"Sci Transl Med"},{"key":"13359_CR42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","volume":"7","author":"C Wider","year":"2010","unstructured":"Wider C, Dickson DW, Wszolek ZK (2010) Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis 7:175\u2013179","journal-title":"Neurodegener Dis"},{"key":"13359_CR43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13359-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:05Z","timestamp":1760524505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13359"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13359-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.19.25327958","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the institutional review board at each site, and participants provided written informed consent. This research was conducted ethically in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"630"}}